DeviceTalks Boston 2017

The most innovative companies in the world are the ones who emphasize speed. But technologies have already sped up the process and the engineering is only one part of the process. When company leadership says “Do it faster” engineers may feel tapped out. They don’t necessarily have more tools or know how to put that directive into action. This panel aims to uncover the secrets of innovating quickly, both in product development and in processes to improve efficiencies. They’ll discuss real-world situations, as well as tools and tips to help meet innovation goals. 

 

*Sponsored by Protolabs 

Improving speed to market and optimizing resources in the medtech industry requires thinking beyond traditional development models.  Increasingly companies are moving towards virtual product development using partners. This panel features industry experts who can help you understand how to select the right partner for your project, protect IP ownership, and successfully build and manage a virtual development team. 

*Sponsored by Minnetronix 

Wearables and mobile apps support fitness, health education, symptom tracking, and collaborative disease management and care coordination. Analytics help interpret data, reducing the amount of time that end users spend piecing together data outputs. However, collecting and managing data and analytics is new(er) territory for medical device OEMs. Moving from physical devices to analytics is a significant process, and companies struggle in marrying the two.

This session will feature panelists who have developed both IoT and data-focused medical devices. These medical device experts will discuss real-world lessons learned in managing the IoT and data analytics of medical devices. Devices equipped with great data analysis will drive the digital disruption of the healthcare world, business processes and real-time decision-making.

Changes at the FDA could alter the way medical technology gets to market. After years of increasing predictability for device companies, will the administration create more uncertainty, or will the industry welcome an era of less regulation? A panel of experts discuss how best to game plan for changes in Silver Spring. 

A discussion with three CEOs of exciting emerging medtech companies that are helping to change the paradigm of care. 

MedTech 3.0 and how data, sensors, wireless technology and advanced materials will change medtech. A panel of experts discusses the trends you need to pay attention to, versus the technologies that are all hype.

*Sponsored by Acorn PD  

 The concept of creating “collision of value” is about building an ecosystem where high potential startup companies interact with valuable partners along their journey. These companies could be large strategic partners, payers, OEMs, investors and more. “Collisions of value” can be planned or serendipitous.

Planned collisions include a formal email introduction, or a business development director reaching out to mentor an early stage startup company on how to get ready to get funded. It could be a startup CEO’s presentation to an industry group which sparks interest from a technology scout sitting in the crowd.

Serendipitous collisions are similar interactions that happen more by chance but not by luck. Putting yourself at the right place at the right time and being fortunate enough to meet a new mentor, or a potential investor. Participating in an industry event where the world’s experts in a niche market gather, listening to a few of them speak, and then introduce your startup to the speaker to get their reaction to the value propositions you are building into your business model, is a great way to sharpen an entrepreneurs tools helping them to break into a new space.

During this two-part panel session and pitch round, MPR and M2D2 will provide real world examples of how these “collisions” have resulted in mutually beneficial partnerships from sr. executives at the company themselves. The presentation is more than just war stories, you'll hear best practices on how to navigate a partnership from both the big and small company perspective from some of the companies who have successfully executed these agreements, like Admetsys, B. Braun, 3Derm and Johnson & Johnson. 

Then, in part two, start up medtech companies will present elevator pitches, specifically aimed at creating partnerships with strategic investors. 

For years now we've heard about the revolution of 3-d printing and how it will change manufacturing. Whether a game changing technology or overhyped fad, this panel will dive into the realities of this technology and its use in medical applications.  

 

·         Financing best practices from early stage to exit

·         IP protection is key to a successful exit

·         FDA regulatory trends

·         Avoiding and mitigating litigation risk 

In part two of "Collissions of Value," 8-10 emerging companies peddle their wares in 3-minute pitch sessions, moderated by M2D2 and MPR Associates. 

Participating companies:

Cam Medical
149 Medical
NE Breath
Nolen Ortho
TrPro Relief
Innovative Trauma Care
Advanced Silicon Group
Prapela 
Embryyo  

Brian Johnson sits down with Anders Wold, President and CEO of GE Healthcare Clinical Care Solutions, GE Healthcare. 

Mr. Wold is responsible for a $5B business with more than 5,000 employees worldwide. Clinical Care Solutions provides clinicians and frontline care-givers with a variety of medical solutions including ultrasound, monitoring technology, maternal infant care, anesthesia and respiratory care, and cardiology. 

In addition, we'll be unveiling our Medical Design & Outsourcing's Big 100 issue.